Skip to main content
. 2023 Jun 16;2023:330–339.

Table 1.

Demographics of study patients. SSI: surgical site infection.

Patient Characteristics SSI (N = 434) No Complication (N = 8751) P value
Age at time of surgery (years), mean (SD) 56.2 (16.0) 52.4 (16.7) < 0.001
Gender, male, n (%) 220 (50.7) 4247 (48.5) 0.41
Race, n (%)
American Indian or Alaska Native Asian
Black or African American
Native Hawaiian or Pacific Islander White
Unknown or not reported

7 (1.6)
3 (0.7)
5 (1.2)
8 (1.8)
398 (91.7)
13 (3.0)

115 (1.3)
133 (1.5)
111 (1.3)
56 (0.6)
8002 (91.4)
334 (3.8)

0.75
0.23
1
0.008
0.92
0.46
Ethnicity, Hispanic, n (%) 36 (8.3) 888 (10.1) 0.24
Inpatient or outpatient status, inpatient, n (%) 321 (74.9) 3467 (39.6) < 0.001
Current Procedural Terminology code, n (%)
0 – 29999 (skin / soft tissue)
30000 – 39999 (cardiovascular)
40000 – 49999 (gastrointestinal)
50000 – 59999 (genitourinary)
60000 – 69999 (nervous system)

38 (8.8)
43 (9.9)
351 (80.9)
2 (0.5)
0 (0)

1403 (16.0)
850 (9.7)
6434 (73.5)
48 (0.5)
16 (0.2)

< 0.001
0.96
< 0.001
1
0.76
Comorbidities, n (%) Diabetes mellitus
Current smoker within 1 year Dyspnea
Dependent functional health status Ventilator dependent
History of severe chronic obstructive pulmonary disease Ascites within 30 days prior to surgery
Congestive heart failure within 30 days prior to surgery Hypertension requiring medication
Acute renal failure
Currently requiring or on dialysis

79 (18.2)
69 (15.9)
30 (6.9)
7 (1.6)
3 (0.7)
15 (3.5)
0 (0)
2 (0.5)
162 (37.3)
0 (0)
5 (1.2)

1130 (12.9)
1089 (12.4)
453 (5.2)
74 (0.8)
13 (0.1)
186 (2.1)
6 (0.07)
20 (0.2)
2745 (31.4)
10 (0.1)
123 (1.4)

0.002
0.04
0.14
0.16
0.04
0.09
1
0.64
0.01
1
0.82
Disseminated cancer 28 (6.5) 252 (2.9) < 0.001
Open wound with or without infection 28 (6.5) 344 (3.9) 0.01
Steroid / immunosuppressant use for chronic condition 50 (11.5) 553 (6.3) < 0.001
>10% loss of body weight in the 6 months prior to surgery 20 (4.6) 128 (1.5) < 0.001
Bleeding disorder 5 (1.2) 152 (1.7) 0.47